ScoreWhy is Traws Pharma, Inc. ?
1
Positive results in Jun 25
- NET SALES(HY) At USD 2.79 MM has Grown at 2,369.03%
- ROCE(HY) Highest at 1,224.29%
- RAW MATERIAL COST(Y) Fallen by -7.59% (YoY)
2
With ROE of 939.05%, it has a does not qualify valuation with a 1.53 Price to Book Value
- Over the past year, while the stock has generated a return of -90.21%, its profits have risen by 410.2%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Traws Pharma, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Traws Pharma, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Traws Pharma, Inc.
-77.57%
-0.77
120.38%
S&P 500
13.99%
0.81
19.85%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
29.91%
EBIT Growth (5y)
-39.55%
EBIT to Interest (avg)
-21.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.66
Sales to Capital Employed (avg)
0.10
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
26.27%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
0
Industry P/E
Price to Book Value
1.53
EV to EBIT
0.14
EV to EBITDA
0.14
EV to Capital Employed
0.68
EV to Sales
-6.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
496.52%
ROE (Latest)
939.05%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend21What is working for the Company
NET SALES(HY)
At USD 2.79 MM has Grown at 2,369.03%
ROCE(HY)
Highest at 1,224.29%
RAW MATERIAL COST(Y)
Fallen by -7.59% (YoY
OPERATING PROFIT(Q)
Highest at USD -1.25 MM
PRE-TAX PROFIT(Q)
Highest at USD -1.06 MM
NET PROFIT(Q)
At USD -0.77 MM has Grown at 86.42%
-4What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -26.94 MM
CASH AND EQV(HY)
Lowest at USD 29.02 MM
Here's what is working for Traws Pharma, Inc.
Net Sales
At USD 2.79 MM has Grown at 2,369.03%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Operating Profit
Highest at USD -1.25 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD -1.06 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD -1.06 MM has Grown at 81.32%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
At USD -0.77 MM has Grown at 86.42%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Raw Material Cost
Fallen by -7.59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Traws Pharma, Inc.
Operating Cash Flow
Lowest at USD -26.94 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Cash and Eqv
Lowest at USD 29.02 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
